Table 4.
Ventricular function at time of cardiotoxicity and at follow-up (n = 16) in patients with only left ventricular dysfunction at the time of cardiotoxicity and in those with biventricular dysfunction.
| Cardiotoxicity | Posttreatment | |
|---|---|---|
| Left ventricular dysfunction n = 10 | ||
| EF Biplane (%) | 44 ± 7 | 51 ± 9 |
| GLS | −15.7 ± 2.4 | −17.6 ± 3.1 |
| FAC (%) | 44 ± 5 | 46 ± 9 |
| RVGLS | −22.2 ± 1.4 | −23.2 ± −5.5 |
| RVFWLS | −27.0 ± 3.2 | −26.1 ± 6.6 |
| Biventricular dysfunction based on RVGLS n = 6 | ||
| EF biplane (%) | 47 ± 3 | 52 ± 3 |
| LV GLS | −14.4 ± 1.7 | −16.4 ± 1.6 |
| FAC | 39 ± 11 | 48 ± 6 |
| RVGLS | −17.8 ± 1.2 | −22.3 ± 2.9 |
| RVFWLS | −21.6 ± 2.8 | −26.3 ± 5.0 |
| Biventricular dysfunction based on RVFWLS n = 3 | ||
| EF biplane (%) | 49 ± 5 | 52 ± 2.5 |
| LV GLS | −15.6 ± 0.8 | −16.1 ± 1.1 |
| FAC | 33 ± 11 | 48 ± 3 |
| RVGLS | −14.6 ± 0.7 | −21.8 ± 2.1 |
| RVFWLS | −19.5 ± 1.1 | −23.5 ± 2.4 |
Abbreviations as per Table 2.